| Quarterly Financials | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 1,566 | 1,576 | 1,918 | 1,839 | 1,797 | 1,853 | 2,156 | 2,209 | 2,032 | 2,091 | 2,326 | 2,307 | 1,768 | 2,252 | 2,234 | 2,421 | 2,381 | 2,515 | 2,662 | 2,750 | 2,699 | 2,835 | 3,202 | 956 | 849 | 933 | 1,108 | 978 | 6,122 | 1,122 | 1,083 | 1,032 | 1,111 |
| Expenses | 1,517 | 1,428 | 1,643 | 1,521 | 1,651 | 1,714 | 1,891 | 1,851 | 1,806 | 1,842 | 1,955 | 1,878 | 1,618 | 1,972 | 1,900 | 2,070 | 2,091 | 2,162 | 2,253 | 2,267 | 2,370 | 2,498 | 2,744 | 687 | 747 | 856 | 806 | 861 | 841 | 869 | 888 | 845 | 881 |
| EBITDA | 49 | 148 | 276 | 318 | 146 | 139 | 265 | 358 | 226 | 249 | 371 | 429 | 150 | 280 | 335 | 351 | 290 | 353 | 409 | 482 | 329 | 337 | 458 | 269 | 102 | 78 | 302 | 117 | 5,281 | 252 | 195 | 187 | 230 |
| Operating Profit % | 3 % | 9 % | 9 % | 15 % | 7 % | 7 % | 12 % | 16 % | 11 % | 12 % | 16 % | 18 % | 8 % | 12 % | 15 % | 13 % | 12 % | 14 % | 15 % | 17 % | 11 % | 11 % | 14 % | 15 % | 11 % | 8 % | 16 % | 12 % | 16 % | 20 % | 15 % | 16 % | 18 % |
| Depreciation | 79 | 95 | 68 | 56 | 74 | 76 | 79 | 78 | 126 | 149 | 140 | 171 | 155 | 153 | 157 | 153 | 153 | 156 | 161 | 170 | 175 | 189 | 198 | 54 | 51 | 54 | 57 | 58 | 60 | 62 | 62 | 64 | 63 |
| Interest | 43 | 46 | 49 | 47 | 40 | 40 | 56 | 55 | 88 | 88 | 72 | 112 | 80 | 75 | 62 | 77 | 67 | 61 | 67 | 62 | 69 | 77 | 87 | 25 | 25 | 30 | 25 | 30 | 29 | 32 | 31 | 32 | 31 |
| Profit Before Tax | -73 | 7 | 158 | 216 | 32 | 24 | 130 | 224 | 12 | 12 | 160 | 146 | -85 | 53 | 115 | 122 | 71 | 135 | 181 | 250 | 85 | 71 | 173 | 190 | 26 | -7 | 221 | 28 | 5,191 | 159 | 102 | 91 | 136 |
| Tax | 7 | 9 | -1 | 10 | 12 | 10 | 17 | 4 | 2 | 5 | 8 | -0 | 4 | 10 | 8 | 5 | 11 | 8 | 13 | 4 | 6 | 17 | 14 | 7 | 6 | 8 | 11 | 31 | 39 | 53 | 38 | 5 | 43 |
| Net Profit | -80 | -3 | 159 | 205 | 20 | 14 | 113 | 220 | 10 | 7 | 151 | 146 | -89 | 42 | 107 | 117 | 60 | 128 | 168 | 246 | 80 | 54 | 159 | 183 | 20 | -15 | 209 | -2 | 5,152 | 106 | 64 | 86 | 94 |
| EPS in ₹ | -1.66 | 0.01 | 3.33 | 4.07 | 0.25 | 0.22 | 2.00 | 4.10 | 0.06 | 0.06 | 2.78 | 2.61 | -1.67 | 0.66 | 1.86 | 2.12 | 0.89 | 2.15 | 2.98 | 4.55 | 1.38 | 0.93 | 2.80 | 3.43 | 0.10 | -0.62 | 3.60 | -0.48 | 103.34 | 1.94 | 1.14 | 1.59 | 1.67 |
Aster DM Healthcare
Aster DM Healthcare
640.25
+4.75
(0.75%)
There are new updates from the company1 day ago
View
Market Cap
33,172.70 Cr
EPS
107.98
PE Ratio
92.17
Dividend Yield
0.76 %
Industry
Healthcare Services52 Week High
675.00
52 Week Low
387.10
PB Ratio
9.27
Debt to Equity
0.47
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from9 analysts
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
 | ||||||||
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
15.12 %
Net Income Growth
64.48 %
Cash Flow Change
169.34 %
ROE
126.54 %
ROCE
87.55 %
EBITDA Margin (Avg.)
31.50 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 6,807 | 7,484 | 8,936 | 12,438 | 11,644 | 12,546 | 14,881 | 17,991 | 6,606 |
| Fixed Assets | 3,520 | 3,738 | 4,289 | 7,124 | 6,749 | 7,009 | 9,052 | 3,175 | 3,920 |
| Current Assets | 2,473 | 2,869 | 3,617 | 4,096 | 3,629 | 4,097 | 4,922 | 14,165 | 1,902 |
| Capital Work in Progress | 290 | 402 | 550 | 736 | 934 | 998 | 279 | 170 | 293 |
| Investments | 32 | 38 | 22 | 34 | 63 | 45 | 80 | 17 | 245 |
| Other Assets | 2,966 | 3,307 | 4,076 | 4,544 | 3,898 | 4,495 | 5,470 | 14,629 | 2,148 |
| Total Liabilities | 6,807 | 7,484 | 8,936 | 12,438 | 11,644 | 12,546 | 14,881 | 17,991 | 6,606 |
| Current Liabilities | 2,201 | 2,224 | 2,668 | 3,722 | 3,196 | 3,559 | 4,655 | 11,288 | 879 |
| Non Current Liabilities | 2,355 | 2,071 | 2,589 | 4,997 | 4,614 | 4,505 | 5,366 | 1,673 | 2,076 |
| Total Equity | 2,251 | 3,190 | 3,680 | 3,719 | 3,834 | 4,483 | 4,861 | 5,030 | 3,651 |
| Reserve & Surplus | 1,034 | 1,953 | 2,334 | 2,401 | 2,501 | 3,080 | 3,574 | 3,686 | 2,554 |
| Share Capital | 403 | 505 | 505 | 497 | 497 | 500 | 500 | 500 | 500 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | 5 | -122 | 61 | 33 | -110 | 120 | 65 | 66 | 332 | 82 |
| Investing Activities | -439 | -775 | -1,136 | -522 | -702 | -658 | -333 | -563 | -951 | -878 | 6,015 |
| Operating Activities | 236 | 203 | 361 | 537 | 601 | 1,223 | 1,569 | 1,314 | 1,834 | 158 | 425 |
| Financing Activities | 203 | 578 | 654 | 46 | 134 | -675 | -1,116 | -686 | -817 | 1,053 | -6,358 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Apr 2025 | Jun 2025 |
| Promoter | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.89 % | 40.38 % | 40.39 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 33.09 % | 29.09 % | 29.09 % | 40.21 % | 29.09 % | 33.48 % | 27.08 % | 23.85 % | 22.62 % | 21.66 % | 11.86 % | 19.64 % |
| DIIs | 7.81 % | 8.73 % | 7.78 % | 7.87 % | 8.12 % | 9.62 % | 8.94 % | 8.93 % | 8.94 % | 8.56 % | 7.64 % | 7.15 % | 13.70 % | 16.35 % | 20.91 % | 22.91 % | 24.59 % | 24.09 % | 25.28 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 3.70 % | 4.44 % | 4.21 % | 4.33 % | 3.92 % | 3.70 % | 3.43 % | 3.34 % | 3.18 % | 3.39 % | 3.15 % | 2.96 % | 3.09 % | 6.98 % | 5.94 % | 5.04 % | 4.38 % | 4.12 % | 3.94 % |
| Others | 50.61 % | 48.94 % | 50.12 % | 49.92 % | 50.08 % | 48.80 % | 49.75 % | 16.76 % | 16.92 % | 17.08 % | 7.11 % | 18.93 % | 7.85 % | 7.72 % | 7.42 % | 7.55 % | 7.49 % | 19.56 % | 10.76 % |
| No of Share Holders | 0 | 78,719 | 93,506 | 87,804 | 80,746 | 80,427 | 78,374 | 80,913 | 82,129 | 71,379 | 67,673 | 67,331 | 80,931 | 2,06,660 | 1,74,171 | 1,59,038 | 1,54,014 | 1,51,664 | 1,48,139 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 120 | 5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.82 | 0.79 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 31 Aug 2023 |  Annual General Meeting | NA | 31 Aug 2023 | 312.45 | 331.20 |
| 23 Apr 2024 |  Dividend | ₹ 118.00 /share | 23 Apr 2024 | 475.25 | 513.35 |
| 22 Aug 2024 | Dividend | ₹ 2.00 /share | 22 Aug 2024 | 375.20 | 401.15 |
| 29 Aug 2024 | Annual General Meeting | NA | 29 Aug 2024 | 379.30 | 409.90 |
| 23 Oct 2024 |  Quarterly Result Announcement | NA | 23 Oct 2024 | 427.95 | 405.20 |
| 31 Jan 2025 | Quarterly Result Announcement | NA | 31 Jan 2025 | 494.65 | 485.30 |
| 10 Feb 2025 | Dividend | ₹ 4.00 /share | 10 Feb 2025 | 485.30 | 473.20 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 550.10 | 584.15 |
| 30 Jul 2025 | Quarterly Result Announcement | NA | 30 Jul 2025 | 595.05 | 590.95 |
| 28 Aug 2025 | Dividend | ₹ 1.00 /share | 28 Aug 2025 | 584.15 | 601.00 |
| 04 Sept 2025 | Annual General Meeting | NA | 04 Sept 2025 | 590.95 | 620.00 |
Announcements
Shareholder Meeting / Postal Ballot-Scrutinizers Report
21 hours ago
21 hours agoShareholder Meeting / Postal Ballot-Outcome of AGM1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationAug 25, 2025
Aug 25, 2025Intimation Regarding 100 Days Campaign - "SAKSHAM NIVESHAK"Aug 23, 2025
Aug 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 12, 2025
Aug 12, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 12, 2025
Aug 12, 2025Reg. 34 (1) Annual Report.Aug 12, 2025
Aug 12, 2025Notice Of 17Th Annual General MeetingAug 12, 2025
Aug 12, 2025General Communication To Shareholders On Deduction Of TDS On Final Dividend For The Financial Year 2024-25Aug 08, 2025
Aug 08, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 30, 2025
Jul 30, 2025General UpdatesJul 30, 2025
Jul 30, 2025Record Date For DividendJul 30, 2025
Jul 30, 2025Results-Financial Results For Jun 30 2025Jul 30, 2025
Jul 30, 2025Board Meeting Outcome for Outcome Of Board MeetingJul 30, 2025
Jul 30, 2025General UpdatesJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-AcquisitionJul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 25, 2025
Jul 25, 2025Board Meeting Intimation for The Approval Of The Unaudited Financial Results For The Quarter Ended June 30 2025Jul 25, 2025
Jul 25, 2025Announcement under Regulation 30 (LODR)-AcquisitionJul 22, 2025
Jul 22, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 19, 2025
Jul 19, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 10, 2025
Jul 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Jul 08, 2025Reply On Clarification Sought On Spurt In VolumeJul 04, 2025
Jul 04, 2025Clarification sought from Aster DM Healthcare LtdJul 04, 2025
Jul 04, 2025Closure of Trading WindowJun 30, 2025
Jun 30, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2025
Jun 17, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AJun 16, 2025
Jun 16, 2025Intimation Of Approval Received For Listing Of 18607969 Equity Shares Of Rs. 10/- Each Allotted On Preferential BasisJun 06, 2025
Jun 06, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 28, 2025
May 28, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 21, 2025
May 21, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 21, 2025
May 21, 2025Announcement Under Regulation 30 Of SEBI (LODR) 2015May 21, 2025
May 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
May 21, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 20, 2025
May 20, 2025Cautionary Letter/EmailMay 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 20, 2025
May 20, 2025Technical Indicators
RSI(14)
Neutral 62.15
ATR(14)
Less Volatile 19.24
STOCH(9,6)
Neutral 62.16
STOCH RSI(14)
Overbought 85.23
MACD(12,26)
Bullish 2.42
ADX(14)
Weak Trend 17.16
UO(9)
Bearish 60.29
ROC(12)
Uptrend And Accelerating 1.76
WillR(14)
Overbought -11.85
Mutual Fund Holdings
HSBC Small Cap Fund Direct-Growth 
UTI Mid Cap Fund Direct-Growth 
Samco Active Momentum Fund Direct - Growth 
Baroda BNP Paribas Health and Wellness Fund Direct-Growth 
HDFC Small Cap Fund Direct- Growth 
Kotak Quant Fund Direct - Growth 
Bandhan Innovation Fund Direct-Growth 
TRUSTMF Small Cap Fund Direct-Growth 
SBI Healthcare Opportunities Fund Direct Plan-Growth 
Motilal Oswal Active Momentum Fund Direct - Growth 
ITI Small Cap Fund Direct-Growth 
Tata Multicap Fund Direct - Growth 
Sundaram Dividend Yield Fund Direct-Growth 
PGIM India Multi Cap Fund Direct-Growth 
Quant Healthcare Fund Direct - Growth 
Aditya Birla Sun Life Bal Bhavishya Yojna Direct-Growth About Aster DM Healthcare
Aster DM Healthcare is a healthcare service provider operating in the GCC and India. Founded in 1987 by Dr. Azad Moopen, the company offers a range of healthcare services through a network of hospitals, clinics, pharmacies, and labs. As of March 2023, Aster DM Healthcare operates 32 hospitals, 127 clinics, 521 pharmacies, and 205 labs and patient experience centers across multiple countries. The company provides primary, secondary, tertiary, and quaternary care, as well as healthcare retailing, diagnostic services, digital health, and medical education. In India, Aster DM Healthcare has 17 hospitals with 4,317 beds, and its operations span across several states including Kerala, Karnataka, Maharashtra, Andhra Pradesh, and Telangana. The company also has a significant presence in GCC countries, with hospitals and clinics in UAE, Oman, Qatar, Bahrain, and Kuwait.
Listing Date
26 Feb, 2018(7 Years,
-20 days)
Chairperson NameMandayapurath Azad Moopen
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
